MSD is expecting to see an additional $200 million layered onto its costs this year as a result of President Trump's tariffs – even before a possible pharma-specific levy is announced. The US pharma ...
Armed with positive results in two phase 3 trials, MSD is poised to be the first drugmaker to file for approval of an oral PCSK9 inhibitor for lowering cholesterol. Top-line results from the CORALreef ...
MSD's booth is seen during an expo in Shanghai in November. [PHOTO/CHINA DAILY] With a long-term commitment to the Chinese market, United States-based global pharmaceutical company MSD plans to ...
Abstract: This article proposes transmitter coils selection method for maximum power transfer efficiency in the wireless power transfer (WPT) system with multiple transmitter coils and a single ...
Abstract: The MINI-magnetically shielded room (MINI-MSR) offers a near-zero magnetic environment for the high performance of optically pumped atomic magnetometers (OPMs) in magnetoencephalography (MEG ...
Soaring Copper Prices Widen the Price Difference Between Primary Metal and Scrap, Yet Market Performance Deviates from Historical Trends Supply-Demand Temperature Gap Amid Production Expansion Wave: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback